Arterra Bioscience SpA

As of December 31, 2024, Arterra Bioscience SpA carries a market capitalization of 12.77M, placing it among publicly traded companies globally. Its enterprise value stands at 9.78M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Arterra Bioscience SpA's next confirmed earnings release is scheduled for March 3, 2027.

As of December 31, 2024, Arterra Bioscience SpA has 6.51M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Arterra Bioscience SpA maintains a current ratio of 9.99, meaning it holds 10.0x the short-term assets needed to cover near-term liabilities.

As of the close on October 22, 2026, Arterra Bioscience SpA's stock has gained approximately 0.00% over the past 52 weeks. The 50-day moving average sits at 3.05, while the 200-day moving average is 3.02.

As of December 31, 2024, Arterra Bioscience SpA holds 3.34M in cash and equivalents against 356,429.00 in total debt, resulting in a net debt position of -2.99M. Total book value stands at 11.42M, with working capital of 7.41M providing operational flexibility.